FDA-Drug2022-06-08Class I
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Teva Pharmaceuticals USA Inc
Hazard
Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Sold states
Distributed Nationwide in the USA
Affected count
4224 cartons
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Anagrelide Capsules USP, 0.5 mg, 100-count bottles, Rx Only, Manufactured in India For: TEVA PHARMACEUTICALS USA, Inc., North Wales, PA 19454. NDC 0172-5241-60.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0992-2022Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief